更新的透明细胞肾细胞癌患者在接受 VEGF 靶向治疗失败后的 EAU 指南。
Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy.
机构信息
The Royal Free NHS Trust and Barts Cancer Institute, Queen Mary University of London, London, UK.
Department of Urology, Ludwig-Maximilians University, Munich, Germany.
出版信息
Eur Urol. 2016 Jan;69(1):4-6. doi: 10.1016/j.eururo.2015.10.017. Epub 2015 Oct 24.
PMID:26508312
Abstract
The European Association of Urology renal cancer guidelines have been updated to recommend nivolumab and cabozantinib over the previous standard of care in patients who have failed one or more lines of VEGF targeted therapy.
摘要
欧洲泌尿外科学会肾癌指南已经更新，建议在 VEGF 靶向治疗失败一线或多线的患者中使用纳武利尤单抗和卡博替尼替代以前的标准治疗。
Zotero 插件